BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 51411819 CCCCCCCCCCCCCCOCC(CNC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O)OCCCCCCCCCCCCCC InChI=1S/C51H82N2O7/c1-3-5-7-9-11-13-15-17-19-21-23-29-37-58-40-42(59-38-30-24-22-20-18-16-14-12-10-8-6-4-2)39-52-49(54)36-35-48(50(55)56)53-51(57)60-41-47-45-33-27-25-31-43(45)44-32-26-28-34-46(44)47/h25-28,31-34,42,47-48H,3-24,29-30,35-41H2,1-2H3,(H,52,54)(H,53,57)(H,55,56) HOSPSDMKMKTFFL-UHFFFAOYSA-N 50570359 CHEMBL4850600 Toll-like receptor 2 Homo sapiens 8700 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570359&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 71735765 471060504 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411820 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NC(=O)OCC1c2ccccc2-c2ccccc12)OCCCCCCCCCCCCCC InChI=1S/C52H87N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-31-39-58-42-44(59-40-32-24-22-20-18-16-14-12-10-8-6-4-2)41-54-51(56)50(37-29-30-38-53)55-52(57)60-43-49-47-35-27-25-33-45(47)46-34-26-28-36-48(46)49/h25-28,33-36,44,49-50H,3-24,29-32,37-43,53H2,1-2H3,(H,54,56)(H,55,57) CZPHJDKEFZBZFX-UHFFFAOYSA-N 50570360 CHEMBL4846103 Toll-like receptor 2 Homo sapiens 1600 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570360 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570360&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134242227 471060505 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411821 CCCCCCCCCCCCCCOCC(CNC(=O)C(CC1CCNCC1)NC(=O)OCC1c2ccccc2-c2ccccc12)OCCCCCCCCCCCCCC InChI=1S/C54H89N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-29-39-60-43-46(61-40-30-24-22-20-18-16-14-12-10-8-6-4-2)42-56-53(58)52(41-45-35-37-55-38-36-45)57-54(59)62-44-51-49-33-27-25-31-47(49)48-32-26-28-34-50(48)51/h25-28,31-34,45-46,51-52,55H,3-24,29-30,35-44H2,1-2H3,(H,56,58)(H,57,59) UKMGQLPWIWPEPH-UHFFFAOYSA-N 50570361 CHEMBL4876723 Toll-like receptor 2 Homo sapiens 1800 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570361 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570361&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231582 471060506 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411822 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H]1CCCN1)OCCCCCCCCCCCCCC InChI=1S/C36H72N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-30-40-33-34(32-38-36(39)35-28-27-29-37-35)41-31-26-24-22-20-18-16-14-12-10-8-6-4-2/h34-35,37H,3-33H2,1-2H3,(H,38,39) YGNDITMOMUEJPZ-UHFFFAOYSA-N 50570362 CHEMBL4862279 Toll-like receptor 2 Homo sapiens 14300 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570362 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570362&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231524 471060507 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411823 CCCCCCCCCCCCCCOCC(CNC(=O)CCN)OCCCCCCCCCCCCCC InChI=1S/C34H70N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-29-38-32-33(31-36-34(37)27-28-35)39-30-26-24-22-20-18-16-14-12-10-8-6-4-2/h33H,3-32,35H2,1-2H3,(H,36,37) HJGNOMMFRMVFNO-UHFFFAOYSA-N 50570363 CHEMBL4850092 Toll-like receptor 2 Homo sapiens 6200 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570363 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570363&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231551 471060508 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411824 CCCCCCCCCCCCCCOCC(CNC(=O)[C@@H](N)CCCCN)OCCCCCCCCCCCCCC InChI=1S/C37H77N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-27-31-42-34-35(33-40-37(41)36(39)29-25-26-30-38)43-32-28-24-22-20-18-16-14-12-10-8-6-4-2/h35-36H,3-34,38-39H2,1-2H3,(H,40,41) QLPZLSAQCVSRIY-UHFFFAOYSA-N 50570364 CHEMBL4852089 Toll-like receptor 2 Homo sapiens 4500 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570364 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570364&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231355 471060509 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411825 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NC(C)=O)OCCCCCCCCCCCCCC InChI=1S/C39H79N3O4/c1-4-6-8-10-12-14-16-18-20-22-24-28-32-45-35-37(34-41-39(44)38(42-36(3)43)30-26-27-31-40)46-33-29-25-23-21-19-17-15-13-11-9-7-5-2/h37-38H,4-35,40H2,1-3H3,(H,41,44)(H,42,43) STTXMJPOJYPITE-UHFFFAOYSA-N 50570365 CHEMBL4874060 Toll-like receptor 2 Homo sapiens 7100 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570365 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570365&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231381 471060510 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411826 CCCCCCCCCCCCCCOCC(CNC(=O)CCCCCN)OCCCCCCCCCCCCCC InChI=1S/C37H76N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-28-32-41-35-36(34-39-37(40)30-26-25-27-31-38)42-33-29-24-22-20-18-16-14-12-10-8-6-4-2/h36H,3-35,38H2,1-2H3,(H,39,40) GZKHIOSBPWAHLA-UHFFFAOYSA-N 50570366 CHEMBL4877760 Toll-like receptor 2 Homo sapiens >20000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570366&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 164628952 471060511 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411827 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H]1CC[C@H](N)CC1)OCCCCCCCCCCCCCC InChI=1S/C38H76N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-31-42-34-37(33-40-38(41)35-27-29-36(39)30-28-35)43-32-26-24-22-20-18-16-14-12-10-8-6-4-2/h35-37H,3-34,39H2,1-2H3,(H,40,41) CXEMIDKFVWNRRV-UHFFFAOYSA-N 50570367 CHEMBL4862067 Toll-like receptor 2 Homo sapiens 3700 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570367 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570367&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134242412 471060512 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411828 CCCCCCCCCCCCCCOCC(CNC(=O)[C@@H](CCCCN)NC(=O)OCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C45H83N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-30-36-51-40-42(52-37-31-24-22-20-18-16-14-12-10-8-6-4-2)38-47-44(49)43(34-28-29-35-46)48-45(50)53-39-41-32-26-25-27-33-41/h25-27,32-33,42-43H,3-24,28-31,34-40,46H2,1-2H3,(H,47,49)(H,48,50) RRYDWJHJBQUMRE-UHFFFAOYSA-N 50570368 CHEMBL4850204 Toll-like receptor 2 Homo sapiens 2300 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570368 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570368&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134242250 471060513 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411829 CCCCCCCCCCCCCCOCC(CNC(=O)C1(CCNCC1)NC(=O)OCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C45H81N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-28-36-51-40-42(52-37-29-24-22-20-18-16-14-12-10-8-6-4-2)38-47-43(49)45(32-34-46-35-33-45)48-44(50)53-39-41-30-26-25-27-31-41/h25-27,30-31,42,46H,3-24,28-29,32-40H2,1-2H3,(H,47,49)(H,48,50) AGIJWFYJPPZHCZ-UHFFFAOYSA-N 50570369 CHEMBL4845765 Toll-like receptor 2 Homo sapiens 2600 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570369 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570369&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134242240 471060514 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411830 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NCc1ccc(F)cc1)OCCCCCCCCCCCCCC InChI=1S/C44H82FN3O3/c1-3-5-7-9-11-13-15-17-19-21-23-27-35-50-39-42(51-36-28-24-22-20-18-16-14-12-10-8-6-4-2)38-48-44(49)43(29-25-26-34-46)47-37-40-30-32-41(45)33-31-40/h30-33,42-43,47H,3-29,34-39,46H2,1-2H3,(H,48,49) PSIAMCQBAQVIJV-UHFFFAOYSA-N 50570370 CHEMBL4877782 Toll-like receptor 2 Homo sapiens 2900 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570370 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570370&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231552 471060515 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411831 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NCc1ccc(cc1)-c1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C50H87N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-30-40-55-44-48(56-41-31-24-22-20-18-16-14-12-10-8-6-4-2)43-53-50(54)49(34-28-29-39-51)52-42-45-35-37-47(38-36-45)46-32-26-25-27-33-46/h25-27,32-33,35-38,48-49,52H,3-24,28-31,34,39-44,51H2,1-2H3,(H,53,54) CQWDPZYLRRTNFO-UHFFFAOYSA-N 50570371 CHEMBL4873132 Toll-like receptor 2 Homo sapiens 2800 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570371 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570371&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231346 471060516 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411832 CCCCCCCCCCCCCCOCC(CNC(=O)[C@@H](CCCCN)NCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C44H83N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-30-36-49-40-42(50-37-31-24-22-20-18-16-14-12-10-8-6-4-2)39-47-44(48)43(34-28-29-35-45)46-38-41-32-26-25-27-33-41/h25-27,32-33,42-43,46H,3-24,28-31,34-40,45H2,1-2H3,(H,47,48) XIXCDMMSWCHMDT-UHFFFAOYSA-N 50570372 CHEMBL4865889 Toll-like receptor 2 Homo sapiens 300 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570372 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570372&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231518 471060517 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411833 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C44H83N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-30-36-49-40-42(50-37-31-24-22-20-18-16-14-12-10-8-6-4-2)39-47-44(48)43(34-28-29-35-45)46-38-41-32-26-25-27-33-41/h25-27,32-33,42-43,46H,3-24,28-31,34-40,45H2,1-2H3,(H,47,48) XIXCDMMSWCHMDT-UHFFFAOYSA-N 50570373 CHEMBL4852939 Toll-like receptor 2 Homo sapiens 200 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570373 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570373&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231424 471060518 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411834 CCCCCCCCCCCCCCOCC(CNC(=O)c1cccc(c1)N1CCNCC1)OCCCCCCCCCCCCCC InChI=1S/C42H77N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-34-47-38-41(48-35-26-24-22-20-18-16-14-12-10-8-6-4-2)37-44-42(46)39-28-27-29-40(36-39)45-32-30-43-31-33-45/h27-29,36,41,43H,3-26,30-35,37-38H2,1-2H3,(H,44,46) VEQPBDRIYPOROE-UHFFFAOYSA-N 50570374 CHEMBL4877055 Toll-like receptor 2 Homo sapiens 6600 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570374&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231544 471060519 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411835 CCCCCCCCCCCCCCOCC(CNC(=O)c1cccc(c1)C1CCNCC1)OCCCCCCCCCCCCCC InChI=1S/C43H78N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-34-47-38-42(48-35-26-24-22-20-18-16-14-12-10-8-6-4-2)37-45-43(46)41-29-27-28-40(36-41)39-30-32-44-33-31-39/h27-29,36,39,42,44H,3-26,30-35,37-38H2,1-2H3,(H,45,46) NKDGYWBRZSCSTQ-UHFFFAOYSA-N 50570375 CHEMBL4856507 Toll-like receptor 2 Homo sapiens 200 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570375 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570375&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231464 471060520 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411836 CCCCCCCOCCNC(=O)[C@H](CCCCN)NCc1ccccc1 |r| InChI=1S/C22H39N3O2/c1-2-3-4-5-11-17-27-18-16-24-22(26)21(14-9-10-15-23)25-19-20-12-7-6-8-13-20/h6-8,12-13,21,25H,2-5,9-11,14-19,23H2,1H3,(H,24,26) RGOCYZSLRLXFAR-UHFFFAOYSA-N 50570376 CHEMBL4846484 Toll-like receptor 2 Homo sapiens 22600 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570376 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570376&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231375 471060521 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411837 CCCCCCCOC(CNC(=O)[C@H](CCCCN)NCc1ccccc1)COC |r| InChI=1S/C24H43N3O3/c1-3-4-5-6-12-17-30-22(20-29-2)19-27-24(28)23(15-10-11-16-25)26-18-21-13-8-7-9-14-21/h7-9,13-14,22-23,26H,3-6,10-12,15-20,25H2,1-2H3,(H,27,28) POOBZROFHKHOPJ-UHFFFAOYSA-N 50570377 CHEMBL4878209 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570377 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570377&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231509 471060522 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411838 CCCCCCCCCCCCCCNC(=O)[C@H](CCCCN)NCc1ccccc1 |r| InChI=1S/C27H49N3O/c1-2-3-4-5-6-7-8-9-10-11-12-18-23-29-27(31)26(21-16-17-22-28)30-24-25-19-14-13-15-20-25/h13-15,19-20,26,30H,2-12,16-18,21-24,28H2,1H3,(H,29,31) LXJLUMBCVCMVTB-UHFFFAOYSA-N 50570378 CHEMBL4868376 Toll-like receptor 2 Homo sapiens 14500 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570378 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570378&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231449 471060523 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411839 CCCCC\C=C/CCCCCCCOCC(CNC(=O)c1cccc(c1)C1CCNCC1)OCCCCCCC\C=C/CCCCC InChI=1S/C43H74N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-34-47-38-42(48-35-26-24-22-20-18-16-14-12-10-8-6-4-2)37-45-43(46)41-29-27-28-40(36-41)39-30-32-44-33-31-39/h11-14,27-29,36,39,42,44H,3-10,15-26,30-35,37-38H2,1-2H3,(H,45,46) IDJYWZXUPYJZFK-UHFFFAOYSA-N 50570379 CHEMBL4877472 Toll-like receptor 2 Homo sapiens 18500 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570379 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570379&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231435 471060524 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411840 CCCCC\C=C/C\C=C/CCCCCCCCOCC(CNC(=O)c1cccc(c1)C1CCNCC1)OCCCCCCCC\C=C/C\C=C/CCCCC InChI=1S/C51H86N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-42-55-46-50(45-53-51(54)49-37-35-36-48(44-49)47-38-40-52-41-39-47)56-43-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h11-14,17-20,35-37,44,47,50,52H,3-10,15-16,21-34,38-43,45-46H2,1-2H3,(H,53,54) UVWFUPXMFMAYRJ-UHFFFAOYSA-N 50570380 CHEMBL4878322 Toll-like receptor 2 Homo sapiens 3300 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570380 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570380&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231420 471060525 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411841 CCCCCCCCCCCCCCOCC(CNC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O)OCCCCCCCCCCCCCC InChI=1S/C51H82N2O7/c1-3-5-7-9-11-13-15-17-19-21-23-29-37-58-40-42(59-38-30-24-22-20-18-16-14-12-10-8-6-4-2)39-52-49(54)36-35-48(50(55)56)53-51(57)60-41-47-45-33-27-25-31-43(45)44-32-26-28-34-46(44)47/h25-28,31-34,42,47-48H,3-24,29-30,35-41H2,1-2H3,(H,52,54)(H,53,57)(H,55,56) HOSPSDMKMKTFFL-UHFFFAOYSA-N 50570359 CHEMBL4850600 Toll-like receptor 2 Homo sapiens 13300 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570359&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 71735765 471060504 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411842 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NC(=O)OCC1c2ccccc2-c2ccccc12)OCCCCCCCCCCCCCC InChI=1S/C52H87N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-31-39-58-42-44(59-40-32-24-22-20-18-16-14-12-10-8-6-4-2)41-54-51(56)50(37-29-30-38-53)55-52(57)60-43-49-47-35-27-25-33-45(47)46-34-26-28-36-48(46)49/h25-28,33-36,44,49-50H,3-24,29-32,37-43,53H2,1-2H3,(H,54,56)(H,55,57) CZPHJDKEFZBZFX-UHFFFAOYSA-N 50570360 CHEMBL4846103 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570360 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570360&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134242227 471060505 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411843 CCCCCCCCCCCCCCOCC(CNC(=O)C(CC1CCNCC1)NC(=O)OCC1c2ccccc2-c2ccccc12)OCCCCCCCCCCCCCC InChI=1S/C54H89N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-29-39-60-43-46(61-40-30-24-22-20-18-16-14-12-10-8-6-4-2)42-56-53(58)52(41-45-35-37-55-38-36-45)57-54(59)62-44-51-49-33-27-25-31-47(49)48-32-26-28-34-50(48)51/h25-28,31-34,45-46,51-52,55H,3-24,29-30,35-44H2,1-2H3,(H,56,58)(H,57,59) UKMGQLPWIWPEPH-UHFFFAOYSA-N 50570361 CHEMBL4876723 Toll-like receptor 2 Homo sapiens 16700 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570361 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570361&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231582 471060506 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411844 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H]1CCCN1)OCCCCCCCCCCCCCC InChI=1S/C36H72N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-30-40-33-34(32-38-36(39)35-28-27-29-37-35)41-31-26-24-22-20-18-16-14-12-10-8-6-4-2/h34-35,37H,3-33H2,1-2H3,(H,38,39) YGNDITMOMUEJPZ-UHFFFAOYSA-N 50570362 CHEMBL4862279 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570362 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570362&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231524 471060507 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411845 CCCCCCCCCCCCCCOCC(CNC(=O)CCN)OCCCCCCCCCCCCCC InChI=1S/C34H70N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-29-38-32-33(31-36-34(37)27-28-35)39-30-26-24-22-20-18-16-14-12-10-8-6-4-2/h33H,3-32,35H2,1-2H3,(H,36,37) HJGNOMMFRMVFNO-UHFFFAOYSA-N 50570363 CHEMBL4850092 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570363 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570363&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231551 471060508 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411846 CCCCCCCCCCCCCCOCC(CNC(=O)[C@@H](N)CCCCN)OCCCCCCCCCCCCCC InChI=1S/C37H77N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-27-31-42-34-35(33-40-37(41)36(39)29-25-26-30-38)43-32-28-24-22-20-18-16-14-12-10-8-6-4-2/h35-36H,3-34,38-39H2,1-2H3,(H,40,41) QLPZLSAQCVSRIY-UHFFFAOYSA-N 50570364 CHEMBL4852089 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570364 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570364&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231355 471060509 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411847 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NC(C)=O)OCCCCCCCCCCCCCC InChI=1S/C39H79N3O4/c1-4-6-8-10-12-14-16-18-20-22-24-28-32-45-35-37(34-41-39(44)38(42-36(3)43)30-26-27-31-40)46-33-29-25-23-21-19-17-15-13-11-9-7-5-2/h37-38H,4-35,40H2,1-3H3,(H,41,44)(H,42,43) STTXMJPOJYPITE-UHFFFAOYSA-N 50570365 CHEMBL4874060 Toll-like receptor 2 Homo sapiens 17000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570365 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570365&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231381 471060510 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411848 CCCCCCCCCCCCCCOCC(CNC(=O)CCCCCN)OCCCCCCCCCCCCCC InChI=1S/C37H76N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-28-32-41-35-36(34-39-37(40)30-26-25-27-31-38)42-33-29-24-22-20-18-16-14-12-10-8-6-4-2/h36H,3-35,38H2,1-2H3,(H,39,40) GZKHIOSBPWAHLA-UHFFFAOYSA-N 50570366 CHEMBL4877760 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570366&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 164628952 471060511 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411849 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H]1CC[C@H](N)CC1)OCCCCCCCCCCCCCC InChI=1S/C38H76N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-31-42-34-37(33-40-38(41)35-27-29-36(39)30-28-35)43-32-26-24-22-20-18-16-14-12-10-8-6-4-2/h35-37H,3-34,39H2,1-2H3,(H,40,41) CXEMIDKFVWNRRV-UHFFFAOYSA-N 50570367 CHEMBL4862067 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570367 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570367&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134242412 471060512 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411850 CCCCCCCCCCCCCCOCC(CNC(=O)[C@@H](CCCCN)NC(=O)OCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C45H83N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-30-36-51-40-42(52-37-31-24-22-20-18-16-14-12-10-8-6-4-2)38-47-44(49)43(34-28-29-35-46)48-45(50)53-39-41-32-26-25-27-33-41/h25-27,32-33,42-43H,3-24,28-31,34-40,46H2,1-2H3,(H,47,49)(H,48,50) RRYDWJHJBQUMRE-UHFFFAOYSA-N 50570368 CHEMBL4850204 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570368 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570368&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134242250 471060513 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411851 CCCCCCCCCCCCCCOCC(CNC(=O)C1(CCNCC1)NC(=O)OCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C45H81N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-28-36-51-40-42(52-37-29-24-22-20-18-16-14-12-10-8-6-4-2)38-47-43(49)45(32-34-46-35-33-45)48-44(50)53-39-41-30-26-25-27-31-41/h25-27,30-31,42,46H,3-24,28-29,32-40H2,1-2H3,(H,47,49)(H,48,50) AGIJWFYJPPZHCZ-UHFFFAOYSA-N 50570369 CHEMBL4845765 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570369 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570369&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134242240 471060514 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411852 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NCc1ccc(F)cc1)OCCCCCCCCCCCCCC InChI=1S/C44H82FN3O3/c1-3-5-7-9-11-13-15-17-19-21-23-27-35-50-39-42(51-36-28-24-22-20-18-16-14-12-10-8-6-4-2)38-48-44(49)43(29-25-26-34-46)47-37-40-30-32-41(45)33-31-40/h30-33,42-43,47H,3-29,34-39,46H2,1-2H3,(H,48,49) PSIAMCQBAQVIJV-UHFFFAOYSA-N 50570370 CHEMBL4877782 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570370 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570370&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231552 471060515 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411853 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NCc1ccc(cc1)-c1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C50H87N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-30-40-55-44-48(56-41-31-24-22-20-18-16-14-12-10-8-6-4-2)43-53-50(54)49(34-28-29-39-51)52-42-45-35-37-47(38-36-45)46-32-26-25-27-33-46/h25-27,32-33,35-38,48-49,52H,3-24,28-31,34,39-44,51H2,1-2H3,(H,53,54) CQWDPZYLRRTNFO-UHFFFAOYSA-N 50570371 CHEMBL4873132 Toll-like receptor 2 Homo sapiens 27900 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570371 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570371&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231346 471060516 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411854 CCCCCCCCCCCCCCOCC(CNC(=O)[C@@H](CCCCN)NCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C44H83N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-30-36-49-40-42(50-37-31-24-22-20-18-16-14-12-10-8-6-4-2)39-47-44(48)43(34-28-29-35-45)46-38-41-32-26-25-27-33-41/h25-27,32-33,42-43,46H,3-24,28-31,34-40,45H2,1-2H3,(H,47,48) XIXCDMMSWCHMDT-UHFFFAOYSA-N 50570372 CHEMBL4865889 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570372 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570372&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231518 471060517 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411855 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C44H83N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-30-36-49-40-42(50-37-31-24-22-20-18-16-14-12-10-8-6-4-2)39-47-44(48)43(34-28-29-35-45)46-38-41-32-26-25-27-33-41/h25-27,32-33,42-43,46H,3-24,28-31,34-40,45H2,1-2H3,(H,47,48) XIXCDMMSWCHMDT-UHFFFAOYSA-N 50570373 CHEMBL4852939 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570373 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570373&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231424 471060518 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411856 CCCCCCCCCCCCCCOCC(CNC(=O)c1cccc(c1)N1CCNCC1)OCCCCCCCCCCCCCC InChI=1S/C42H77N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-34-47-38-41(48-35-26-24-22-20-18-16-14-12-10-8-6-4-2)37-44-42(46)39-28-27-29-40(36-39)45-32-30-43-31-33-45/h27-29,36,41,43H,3-26,30-35,37-38H2,1-2H3,(H,44,46) VEQPBDRIYPOROE-UHFFFAOYSA-N 50570374 CHEMBL4877055 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570374&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231544 471060519 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411857 CCCCCCCCCCCCCCOCC(CNC(=O)c1cccc(c1)C1CCNCC1)OCCCCCCCCCCCCCC InChI=1S/C43H78N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-34-47-38-42(48-35-26-24-22-20-18-16-14-12-10-8-6-4-2)37-45-43(46)41-29-27-28-40(36-41)39-30-32-44-33-31-39/h27-29,36,39,42,44H,3-26,30-35,37-38H2,1-2H3,(H,45,46) NKDGYWBRZSCSTQ-UHFFFAOYSA-N 50570375 CHEMBL4856507 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570375 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570375&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231464 471060520 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411858 CCCCCCCOCCNC(=O)[C@H](CCCCN)NCc1ccccc1 |r| InChI=1S/C22H39N3O2/c1-2-3-4-5-11-17-27-18-16-24-22(26)21(14-9-10-15-23)25-19-20-12-7-6-8-13-20/h6-8,12-13,21,25H,2-5,9-11,14-19,23H2,1H3,(H,24,26) RGOCYZSLRLXFAR-UHFFFAOYSA-N 50570376 CHEMBL4846484 Toll-like receptor 2 Homo sapiens 13700 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570376 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570376&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231375 471060521 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411859 CCCCCCCOC(CNC(=O)[C@H](CCCCN)NCc1ccccc1)COC |r| InChI=1S/C24H43N3O3/c1-3-4-5-6-12-17-30-22(20-29-2)19-27-24(28)23(15-10-11-16-25)26-18-21-13-8-7-9-14-21/h7-9,13-14,22-23,26H,3-6,10-12,15-20,25H2,1-2H3,(H,27,28) POOBZROFHKHOPJ-UHFFFAOYSA-N 50570377 CHEMBL4878209 Toll-like receptor 2 Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570377 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570377&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231509 471060522 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411860 CCCCCCCCCCCCCCNC(=O)[C@H](CCCCN)NCc1ccccc1 |r| InChI=1S/C27H49N3O/c1-2-3-4-5-6-7-8-9-10-11-12-18-23-29-27(31)26(21-16-17-22-28)30-24-25-19-14-13-15-20-25/h13-15,19-20,26,30H,2-12,16-18,21-24,28H2,1H3,(H,29,31) LXJLUMBCVCMVTB-UHFFFAOYSA-N 50570378 CHEMBL4868376 Toll-like receptor 2 Homo sapiens 11300 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570378 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570378&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231449 471060523 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411861 CCCCC\C=C/CCCCCCCOCC(CNC(=O)c1cccc(c1)C1CCNCC1)OCCCCCCC\C=C/CCCCC InChI=1S/C43H74N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-34-47-38-42(48-35-26-24-22-20-18-16-14-12-10-8-6-4-2)37-45-43(46)41-29-27-28-40(36-41)39-30-32-44-33-31-39/h11-14,27-29,36,39,42,44H,3-10,15-26,30-35,37-38H2,1-2H3,(H,45,46) IDJYWZXUPYJZFK-UHFFFAOYSA-N 50570379 CHEMBL4877472 Toll-like receptor 2 Homo sapiens 16900 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570379 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570379&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231435 471060524 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411862 CCCCC\C=C/C\C=C/CCCCCCCCOCC(CNC(=O)c1cccc(c1)C1CCNCC1)OCCCCCCCC\C=C/C\C=C/CCCCC InChI=1S/C51H86N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-42-55-46-50(45-53-51(54)49-37-35-36-48(44-49)47-38-40-52-41-39-47)56-43-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h11-14,17-20,35-37,44,47,50,52H,3-10,15-16,21-34,38-43,45-46H2,1-2H3,(H,53,54) UVWFUPXMFMAYRJ-UHFFFAOYSA-N 50570380 CHEMBL4878322 Toll-like receptor 2 Homo sapiens 16100 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570380 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=397&target=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570380&enzyme=Toll-like+receptor+2&column=ki&startPg=0&Increment=50&submit=Search 134231420 471060525 1 MPHTLWMVWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFDDCTLNGVGNFRASDNDRVIDPGKVETLTIRRLHIPRFYLFYDLSTLYSLTERVKRITVENSKVFLVPCLLSQHLKSLEYLDLSENLMVEEYLKNSACEDAWPSLQTLILRQNHLASLEKTGETLLTLKNLTNIDISKNSFHSMPETCQWPEKMKYLNLSSTRIHSVTGCIPKTLEILDVSNNNLNLFSLNLPQLKELYISRNKLMTLPDASLLPMLLVLKISRNAITTFSKEQLDSFHTLKTLEAGGNNFICSCEFLSFTQEQQALAKVLIDWPANYLCDSPSHVRGQQVQDVRLSVSECHRTALVSGMCCALFLLILLTGVLCHRFHGLWYMKMMWAWLQAKRKPRKAPSRNICYDAFVSYSERDAYWVENLMVQELENFNPPFKLCLHKRDFIPGKWIIDNIIDSIEKSHKTVFVLSENFVKSEWCKYELDFSHFRLFDENNDAAILILLEPIEKKAIPQRFCKLRKIMNTKTYLEWPMDEAQREGFWVNLRAAIKS 1FYW Toll-like receptor 2 TLR2_HUMAN O60603 B3Y612 D1CS45 D1CS48 D1CS49 O15454 Q8NI00 51411863 CCCCCCCCCCCCCCOCC(CNC(=O)CCN)OCCCCCCCCCCCCCC InChI=1S/C34H70N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-29-38-32-33(31-36-34(37)27-28-35)39-30-26-24-22-20-18-16-14-12-10-8-6-4-2/h33H,3-32,35H2,1-2H3,(H,36,37) HJGNOMMFRMVFNO-UHFFFAOYSA-N 50570363 CHEMBL4850092 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570363 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570363&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231551 471060508 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411864 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H]1CCCN1)OCCCCCCCCCCCCCC InChI=1S/C36H72N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-30-40-33-34(32-38-36(39)35-28-27-29-37-35)41-31-26-24-22-20-18-16-14-12-10-8-6-4-2/h34-35,37H,3-33H2,1-2H3,(H,38,39) YGNDITMOMUEJPZ-UHFFFAOYSA-N 50570362 CHEMBL4862279 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570362 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570362&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231524 471060507 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411865 CCCCCCCCCCCCCCOCC(CNC(=O)C(CC1CCNCC1)NC(=O)OCC1c2ccccc2-c2ccccc12)OCCCCCCCCCCCCCC InChI=1S/C54H89N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-29-39-60-43-46(61-40-30-24-22-20-18-16-14-12-10-8-6-4-2)42-56-53(58)52(41-45-35-37-55-38-36-45)57-54(59)62-44-51-49-33-27-25-31-47(49)48-32-26-28-34-50(48)51/h25-28,31-34,45-46,51-52,55H,3-24,29-30,35-44H2,1-2H3,(H,56,58)(H,57,59) UKMGQLPWIWPEPH-UHFFFAOYSA-N 50570361 CHEMBL4876723 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570361 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570361&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231582 471060506 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411866 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NC(=O)OCC1c2ccccc2-c2ccccc12)OCCCCCCCCCCCCCC InChI=1S/C52H87N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-31-39-58-42-44(59-40-32-24-22-20-18-16-14-12-10-8-6-4-2)41-54-51(56)50(37-29-30-38-53)55-52(57)60-43-49-47-35-27-25-33-45(47)46-34-26-28-36-48(46)49/h25-28,33-36,44,49-50H,3-24,29-32,37-43,53H2,1-2H3,(H,54,56)(H,55,57) CZPHJDKEFZBZFX-UHFFFAOYSA-N 50570360 CHEMBL4846103 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570360 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570360&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134242227 471060505 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411867 CCCCCCCCCCCCCCOCC(CNC(=O)CC[C@H](NC(=O)OCC1c2ccccc2-c2ccccc12)C(O)=O)OCCCCCCCCCCCCCC InChI=1S/C51H82N2O7/c1-3-5-7-9-11-13-15-17-19-21-23-29-37-58-40-42(59-38-30-24-22-20-18-16-14-12-10-8-6-4-2)39-52-49(54)36-35-48(50(55)56)53-51(57)60-41-47-45-33-27-25-31-43(45)44-32-26-28-34-46(44)47/h25-28,31-34,42,47-48H,3-24,29-30,35-41H2,1-2H3,(H,52,54)(H,53,57)(H,55,56) HOSPSDMKMKTFFL-UHFFFAOYSA-N 50570359 CHEMBL4850600 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570359&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 71735765 471060504 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411868 CCCCCCCCCCCCCCOCC(CNC(=O)[C@@H](N)CCCCN)OCCCCCCCCCCCCCC InChI=1S/C37H77N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-27-31-42-34-35(33-40-37(41)36(39)29-25-26-30-38)43-32-28-24-22-20-18-16-14-12-10-8-6-4-2/h35-36H,3-34,38-39H2,1-2H3,(H,40,41) QLPZLSAQCVSRIY-UHFFFAOYSA-N 50570364 CHEMBL4852089 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570364 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570364&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231355 471060509 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411869 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NC(C)=O)OCCCCCCCCCCCCCC InChI=1S/C39H79N3O4/c1-4-6-8-10-12-14-16-18-20-22-24-28-32-45-35-37(34-41-39(44)38(42-36(3)43)30-26-27-31-40)46-33-29-25-23-21-19-17-15-13-11-9-7-5-2/h37-38H,4-35,40H2,1-3H3,(H,41,44)(H,42,43) STTXMJPOJYPITE-UHFFFAOYSA-N 50570365 CHEMBL4874060 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570365 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570365&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231381 471060510 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411870 CCCCCCCCCCCCCCOCC(CNC(=O)CCCCCN)OCCCCCCCCCCCCCC InChI=1S/C37H76N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-28-32-41-35-36(34-39-37(40)30-26-25-27-31-38)42-33-29-24-22-20-18-16-14-12-10-8-6-4-2/h36H,3-35,38H2,1-2H3,(H,39,40) GZKHIOSBPWAHLA-UHFFFAOYSA-N 50570366 CHEMBL4877760 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570366&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 164628952 471060511 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411871 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H]1CC[C@H](N)CC1)OCCCCCCCCCCCCCC InChI=1S/C38H76N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-31-42-34-37(33-40-38(41)35-27-29-36(39)30-28-35)43-32-26-24-22-20-18-16-14-12-10-8-6-4-2/h35-37H,3-34,39H2,1-2H3,(H,40,41) CXEMIDKFVWNRRV-UHFFFAOYSA-N 50570367 CHEMBL4862067 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570367 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570367&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134242412 471060512 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411872 CCCCCCCCCCCCCCOCC(CNC(=O)[C@@H](CCCCN)NC(=O)OCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C45H83N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-30-36-51-40-42(52-37-31-24-22-20-18-16-14-12-10-8-6-4-2)38-47-44(49)43(34-28-29-35-46)48-45(50)53-39-41-32-26-25-27-33-41/h25-27,32-33,42-43H,3-24,28-31,34-40,46H2,1-2H3,(H,47,49)(H,48,50) RRYDWJHJBQUMRE-UHFFFAOYSA-N 50570368 CHEMBL4850204 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570368 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570368&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134242250 471060513 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411873 CCCCCCCCCCCCCCOCC(CNC(=O)C1(CCNCC1)NC(=O)OCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C45H81N3O5/c1-3-5-7-9-11-13-15-17-19-21-23-28-36-51-40-42(52-37-29-24-22-20-18-16-14-12-10-8-6-4-2)38-47-43(49)45(32-34-46-35-33-45)48-44(50)53-39-41-30-26-25-27-31-41/h25-27,30-31,42,46H,3-24,28-29,32-40H2,1-2H3,(H,47,49)(H,48,50) AGIJWFYJPPZHCZ-UHFFFAOYSA-N 50570369 CHEMBL4845765 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570369 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570369&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134242240 471060514 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411874 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NCc1ccc(F)cc1)OCCCCCCCCCCCCCC InChI=1S/C44H82FN3O3/c1-3-5-7-9-11-13-15-17-19-21-23-27-35-50-39-42(51-36-28-24-22-20-18-16-14-12-10-8-6-4-2)38-48-44(49)43(29-25-26-34-46)47-37-40-30-32-41(45)33-31-40/h30-33,42-43,47H,3-29,34-39,46H2,1-2H3,(H,48,49) PSIAMCQBAQVIJV-UHFFFAOYSA-N 50570370 CHEMBL4877782 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570370 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570370&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231552 471060515 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411875 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NCc1ccc(cc1)-c1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C50H87N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-30-40-55-44-48(56-41-31-24-22-20-18-16-14-12-10-8-6-4-2)43-53-50(54)49(34-28-29-39-51)52-42-45-35-37-47(38-36-45)46-32-26-25-27-33-46/h25-27,32-33,35-38,48-49,52H,3-24,28-31,34,39-44,51H2,1-2H3,(H,53,54) CQWDPZYLRRTNFO-UHFFFAOYSA-N 50570371 CHEMBL4873132 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570371 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570371&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231346 471060516 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411876 CCCCCCCCCCCCCCOCC(CNC(=O)[C@@H](CCCCN)NCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C44H83N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-30-36-49-40-42(50-37-31-24-22-20-18-16-14-12-10-8-6-4-2)39-47-44(48)43(34-28-29-35-45)46-38-41-32-26-25-27-33-41/h25-27,32-33,42-43,46H,3-24,28-31,34-40,45H2,1-2H3,(H,47,48) XIXCDMMSWCHMDT-UHFFFAOYSA-N 50570372 CHEMBL4865889 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570372 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570372&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231518 471060517 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411877 CCCCCCCCCCCCCCOCC(CNC(=O)[C@H](CCCCN)NCc1ccccc1)OCCCCCCCCCCCCCC InChI=1S/C44H83N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-30-36-49-40-42(50-37-31-24-22-20-18-16-14-12-10-8-6-4-2)39-47-44(48)43(34-28-29-35-45)46-38-41-32-26-25-27-33-41/h25-27,32-33,42-43,46H,3-24,28-31,34-40,45H2,1-2H3,(H,47,48) XIXCDMMSWCHMDT-UHFFFAOYSA-N 50570373 CHEMBL4852939 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570373 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570373&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231424 471060518 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411878 CCCCCCCCCCCCCCOCC(CNC(=O)c1cccc(c1)N1CCNCC1)OCCCCCCCCCCCCCC InChI=1S/C42H77N3O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-34-47-38-41(48-35-26-24-22-20-18-16-14-12-10-8-6-4-2)37-44-42(46)39-28-27-29-40(36-39)45-32-30-43-31-33-45/h27-29,36,41,43H,3-26,30-35,37-38H2,1-2H3,(H,44,46) VEQPBDRIYPOROE-UHFFFAOYSA-N 50570374 CHEMBL4877055 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570374&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231544 471060519 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3 51411879 CCCCCCCCCCCCCCOCC(CNC(=O)c1cccc(c1)C1CCNCC1)OCCCCCCCCCCCCCC InChI=1S/C43H78N2O3/c1-3-5-7-9-11-13-15-17-19-21-23-25-34-47-38-42(48-35-26-24-22-20-18-16-14-12-10-8-6-4-2)37-45-43(46)41-29-27-28-40(36-41)39-30-32-44-33-31-39/h27-29,36,39,42,44H,3-26,30-35,37-38H2,1-2H3,(H,45,46) NKDGYWBRZSCSTQ-UHFFFAOYSA-N 50570375 CHEMBL4856507 Tumor necrosis factor Homo sapiens >30000 ChEMBL 10.1016/j.bmcl.2021.127861 10.7270/Q2CR5Z4W 33636302 Natala, SR; Habas, A; Stocking, EM; Orry, A; Price, DL; Gill, MB; Bonhaus, DW; Abagyan, R; Wrasidlo, W 5/15/2021 8/20/2022 Neuropore Therapies http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50570375 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5625&target=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50570375&enzyme=Tumor+necrosis+factor&column=ki&startPg=0&Increment=50&submit=Search 134231464 471060520 1 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL 5MU8,9OK6,9OJY,9OJS,9OJO,6X86,6X85,6X83,6X82,6X81,5YOY,7JRA,9BN7,8Z8M,6OOZ,6OOY,5WUX,5M2M,5M2J,5M2I,4TWT,4G3Y,9DJW,3IT8,3ALQ,3L9J,2AZ5,7ASY,7QLF Tumor necrosis factor TNFA_HUMAN P01375 O43647 Q9P1Q2 Q9UIV3